|
Society for Behavioral
Neuroendocrinology |
| Preconference Workshop | 2006 Meeting Home Page |
| Preconference Workshop:
Sexual Function and Dysfunction in Humans (Chair: Emilie Rissman) |
|
| 1:10 p.m. | The epidemiology of human sexual dysfunction:
Prevalence and risk factors from the National Health and Social Life
Survey (NHSLS) and the Global Study of Sexual Attitudes and Behavior
(GSSAB) Edward O. Laumann (University of Chicago) |
| 1:35 p.m. | Sexuality after Cancer Leslie Schover (MD Anderson Cancer Research Center) |
| 2:00 p.m. | PT-141: A melanocortin agonist for the treatment
of male and female sexual dysfunction Annette M Shadiack (Palatin Technologies) |
| 2:25 – 2:50 p.m. | Coffee Break |
| 2:50 p.m. | Control of ejaculation: What the rat's brain
tells the clinician Elaine Hull (Florida State University) |
| 3:15 p.m. | Assessment of sexual arousal in rats
Ben Sachs (University of Connecticut) |
| 3:40 p.m. | The role of androgen and estrogen in female
sexual desire Kim Wallen (Emory University) |
| 4:05-5:00 p.m. |
Break into small groups for discussion Determinants of Sexual Arousal : Sachs and Schover Male Sexual Dysfunction : Female Sexual Function : Wallen and Shadiack |
| 5:00 – 5:30 p.m. | Reconvene for small group reports |
Workshop Description and Goals
Sexual function is an important concern for both men and women. Some estimate that 20% of normal woman are non-orgasmic, 30% of men have experienced erectile dysfunction, and 40% display premature ejaculation. Not only has the pharmaceutical industry become interested in this topic, it is also a major quality of life issue for many cancer survivors. Given that many members of SBN have expertise in this topic it is timely to bring together researchers from a number of disciplines who study both normal and impaired sexual function. This workshop will provide an opportunity and forum for this diverse group to meet, discuss both common and unique issues, unifying themes, and the potential for animal models.
The format for the workshop will include short presentations from the speakers listed. Next we will form small groups (audience and speakers together) to address the hot topics listed below, and any others that follow from the presentations. At the end of the afternoon each small group will report back to the entire group.
Hot topics:
1. Libido in women: evolution, function, animal models and pharmaceutical applications
2. The role of psychosocial factors in coping with the sexual dysfunction caused by cancer treatment
3. What is normal sexuality in men and women?
4. Roles for testosterone and estradiol in sexual desire in men and women; myths and data
5. Orgasmic dysfunction, including treatments and prevalence of premature ejaculation; animal work?
6. How are sexual arousal and desire quantified; do we have animal models and is it possible to develop them?
| Contents © 2006 Society for Behavioral Neuroendocrinology | 2006 Meeting Home Page |